GAITHERSBURG, Md., June 5, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has…
Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab…
Entrepreneurs-in-Residence (EIR) Team Continues Growth With National Institutes of Health (NIH) ROCKVILLE, MARYLAND, May 30, 2023 – BioHealth Innovation Inc. (BHI)…